Molecular Oncology of Gaithersburg, Md., as part of theformation of a new therapeutics division, has reorganized itssenior management. Charles N. Blitzer was named presidentand chief executive officer; Paul H. Fischer was appointedexecutive vice president of research and development; WilliamA. Bundy will become chief operating officer and the presidentof the diagnostics division; David R. Crockford is now vicepresident for regulatory affairs; Michael L. Berman was nameddirector of business development and Kyparissia K. Sirinakiswas appointed director of finance.
Advanced Tissue Sciences Inc. of La Jolla, Calif., named David S.Tappan Jr. to its board of directors. Tappan is a director forFluor Corp. and Genentech Inc., Allianz Insurance Co., BeckmanInstruments Inc., the University of Southern California Board ofTrustees and the Scripps Research Institute.
Biomedical Corp. of Vancouver, British Columbia, named John G.Hayes to its board of directors. Hayes was founder and chiefexecutive officer of Lifescan, also of Vancouver.
(c) 1997 American Health Consultants. All rights reserved.